Is elective cancer surgery feasible during the lock-down period of the COVID-19 pandemic? Analysis of a single institutional experience of 404 consecutive patients.
Cemil Burak KulleIbrahim Fethi AzamatDoğan VatanseverSuat ErusKayhan TarimGoktug AkyoldasOzan GoklerMehmet Ali DeveciNahit CakarOnder ErgonulOrhan AgcaogluMurat Can KiremitOmer YavuzTalat KirisSelin UnsalerBurak GirayMurat KorkmazEce DilegeMert KilicEzgi CesurIhsan SolarogluOzan AltuntasAykin SimsekSerhan TanjuMert ErkanErdem CandaMehdi SasaniAysenur Meric HafizYakup KordanEmre BalikOrhan BilgeDursun BugraCagatay TaskiranSukru DilegePublished in: Journal of surgical oncology (2021)
Under strict institutional policies and measures to establish a COVID-19-free surgical pathway, elective and emergency cancer operations can be performed with acceptable perioperative and postoperative morbidity and mortality.
Keyphrases
- patients undergoing
- papillary thyroid
- public health
- end stage renal disease
- squamous cell
- coronavirus disease
- minimally invasive
- newly diagnosed
- ejection fraction
- sars cov
- emergency department
- chronic kidney disease
- healthcare
- prognostic factors
- lymph node metastasis
- peritoneal dialysis
- squamous cell carcinoma
- coronary artery bypass
- young adults
- atrial fibrillation